Complex sphingolipids play critical roles in various cellular events in the yeast Saccharomyces cerevisiae. To identify genes that are related to the growth defect caused by disruption of complex sphingolipid biosynthesis, we screened for suppressor mutations and multicopy suppressor genes that confer resistance against repression of AUR1 encoding inositol phosphorylceramide synthase. From the results of this screening, we found that the activation of highosmolarity glycerol (HOG) pathway is involved in suppression of growth defect caused by impaired biosynthesis of complex sphingolipids. Furthermore, it was found that transcriptional regulation via Msn2, Msn4 and Sko1 is involved in the suppressive effect of the HOG pathway. Lack of the HOG pathway did not enhance the reductions in complex sphingolipid levels or the increase in ceramide level caused by the AUR1 repression, implying that the suppressive effect of the HOG pathway on the growth defect is not attributed to restoration of impaired biosynthesis of complex sphingolipids. On the contrary, the HOG pathway and Msn2/4-mediated transcriptional activation was involved in suppression of aberrant reactive oxygen species accumulation caused by the AUR1 repression. These results indicated that the HOG pathway plays pivotal roles in maintaining cell growth under impaired biosynthesis of complex sphingolipids.
Introduction
Complex sphingolipids, some of the major components of the biomembranes of eukaryotic organisms, dynamically cluster with sterol molecules to form lipid microdomains (called lipid rafts), and play critical roles in regulation of signal transduction and membrane trafficking, and stress adaptation (Dickson et al., 2006; Dickson, 2010; Simons and Sampaio, 2011) . Complex sphingolipids are composed of a polar head group and a ceramide (Cer) backbone, which comprises a fatty acid and a long-chain base (LCB). The degradation products or metabolic intermediates of membrane complex sphingolipids, such as Cers, LCBs and LCB 1-phosphates, can act as lipid signaling molecules regulating cellular proliferation, differentiation and death (Dickson et al., 2006; Dickson, 2010) .
In the yeast Saccharomyces cerevisiae, depletion of all sphingolipids causes a lethal phenotype. Among the sphingolipid-metabolizing enzymes, LCB1 and LCB2 encoding serine palmitoyltransferase (SPT), TSC10 encoding 3-ketodihydrosphingosine reductase and AUR1 encoding inositol phosphorylceramide (IPC) synthase are essential for cell growth (Dickson et al., 2006) (Fig. 1A) . The deletion of LCB1, LCB2 or TSC10 causes loss of LCBs including dihydrosphingsoine and phytosphingosine, LCB 1-phosphates, Cers and complex sphingolipids, and consequently loss of the ability to grow; however, deletion mutants lacking these enzyme genes can survive if dihydrosphingosine or phytosphingosine is exogenously supplied (Wells and Lester, 1983) . It should be noted that exogenous supplied sphingosine, which is a major LCB in mammals but not present in S. cerevisiae, can also rescue the growth of LCB2-deleted yeast cells only when phosphorylation of sphingosine is inhibited by deletion of LCB kinase LCB4, indicating that sphingosine can substitute for endogenous LCBs in yeast (Tani et al., 2006) .
Aur1 catalyzes the transfer of the head group of phosphatidylinositol (PI) to Cers and synthesizes IPC, the simplest complex sphingolipid in yeast (Nagiec et al., 1997) (Fig. 1A) . Inhibition of the activity of Aur1 results in a strong growth defect due to depletion of all complex sphingolipids and accumulation of Cers (Nagiec et al., 1997) . Although the chain length of fatty acids in Cers is primarily C26, deletion of ELO3, which is involved in the synthesis of C26 fatty acyl-CoA, confers resistance to the growth defect by repression of expression of AUR1, suggesting that the toxicity of the accumulated Cers on the AUR1 repression depends on the chain length of fatty acids in Cers (Tani and Kuge, 2010a) . Moreover, loss of sphingolipid hydroxylase affects the growth defect caused by the AUR1 repression; that is, deletion of SCS7 involved in hydroxylation at the C-2 position of fatty acids in Cers causes hypersensitivity to the AUR1 repression whereas deletion of SUR2 involved in hydroxylation at the C-4 position of LCBs confers resistance to the repression, suggesting that the hydroxylation state of Cer determines the sensitivity to the AUR1 repression (Tani and Kuge, 2012) . In addition, A. De novo sphingolipid biosynthesis pathway in yeast Saccharomyces cerevisiae. The pathway and proteins responsible for the synthesis of yeast sphingolipids are shown. Cer, ceramide; IPC, inositol phosphorylceramide; LCB, long chain base; MIPC, mannosylinositol phosphorylceramide; M(IP) 2 C, mannosyldiinositol phosphorylceramide. B. Growth defect caused by repression of AUR1. Wild-type and tet-AUR1 cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without 10 mg/ml doxycycline (Dox) in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. All plates were incubated at 308C and photographed after 2 days. C and D. Effects of deletion of genes identified on transposon mutagenesis screening on the AUR1 repression. Deletion of each gene in tet-AUR1 (C) or tet-LCB1 (D) cells was performed by replacing the entire open reading frame with the antibiotic-resistance cassette. E, tet-AUR1 cells harboring pRS425-MSN2 or the empty plasmid were cultured in SC lacking leucine (SC-Leu), and then spotted onto SC-Leu plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. F, effects of overexpression MSN2 by the TEF promoter on the growth defect caused by the AUR1 repression. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml.
AUR1-deleted cells are barely able to maintain cell growth when endogenous Cer synthases are replaced by an enzyme from cotton, which results in production of C18-Cers instead of C26-Cers (Epstein et al., 2012) . Thus, it is indicated that the biosynthesis of complex sphingolipids is not essential for cell growth when the toxicity of Cers is weak. However, AUR1-deleted S. cerevisiae expressing C18-Cers instead of C26-Cers exhibits very slow growth and a defect in cytokinesis, indicating that complex sphingolipids are required for normal cell growth and division (Epstein et al., 2012) . In addition, it has been reported that reduction in complex sphingolipid levels on the inhibition of Aur1 induces the mitochondrial-dependent apoptotic cell death pathway (Kajiwara et al., 2012) .
A lack of LAG1 and LAC1 encoding Cer synthases or LIP1 encoding an essential regulatory subunit of Cer synthases causes a severe growth defect due to a decrease in Cer synthesis and subsequent decreases in complex sphingolipid levels; however, the production of complex sphingolipids is not completely abolished (Guillas et al., 2001; Schorling et al., 2001) (Fig. 1A) . When the activity of Cer synthases is severely compromised, alkaline ceramidases, Ypc1 and Ydc1, catalyze the reverse hydrolysis reaction, which condenses LCBs and free fatty acids to yield Cers, and partly complements the defect of Cer synthases (Schorling et al., 2001) . However, lag1D lac1D ypc1D ydc1D cells exhibit a very severe growth defect but are still viable and able to synthesize only trace levels of complex sphingolipids through an unknown pathway of Cer biosynthesis (Schorling et al., 2001) .
When de novo biosynthesis of sphingolipids is impaired, target of rapamycin complex 2, TORC2, plays important roles in the maintenance of sphingolipid levels through activation of Ypk1 and Ypk2 kinases (Aronova et al., 2008; Roelants et al., 2011; Berchtold et al., 2012) . Under normal conditions, SPT forms a complex with Orm1 and Orm2, negative regulators of SPT and the enzyme activity is partly suppressed (Breslow et al., 2010; Han et al., 2010) ; however, when cells are treated with myriocin, an inhibitor of SPT, Ypk1/2 are activated through TORC2 and phosphorylate Orm1/2, which causes dissociation of the Orm1/2 from SPT and consequently the enzyme activity of SPT is upregulated (Roelants et al., 2011) . This upregulation results in suppression of the growth defect caused by myriocin treatment (Breslow et al., 2010; Roelants et al., 2011) . In addition, Ypk1 activated by TORC2 also phosphorylates Lag1 and Lac1, and upregulates the complex sphingolipid levels (Muir et al., 2014) . These regulations are thought to represent positive feedback regulation of sphingolipid metabolism and to be involved in suppression of the growth defect caused by impaired biosynthesis of sphingolipids.
In this study, to identify genes that are related to the growth defect caused by impaired biosynthesis of complex sphingolipids, we screened for suppressor mutations and multicopy suppressor genes that confer resistance to the repression of AUR1 expression. Through this screening, we found that the high-osmolarity glycerol (HOG) pathway and its downstream transcriptional activation via general stress-responsive transcriptional regulators, including Msn2, Msn4 and Sko1, plays an important role in suppression of the growth defect caused by the impaired biosynthesis of complex sphingolipids.
Results
Screening of suppressor mutations and multicopy suppressors that confer resistance to the growth defect caused by AUR1 repression
To identify genes related to the growth defect caused by impaired biosynthesis of complex sphingolipids, we screened for suppressor mutations that confer resistance to repression of AUR1 expression. To repress AUR1, we used a mutant strain that carries the AUR1 gene under the control of the tetracycline-regulatable (Tet) promoter (tet-AUR1) (Belli et al., 1998; Tani and Kuge, 2010a) . As shown in Fig. 1B , tet-AUR1 cells exhibited a strong growth defect in the presence of 10 mg/ml of doxycycline (Dox), which represses expression of the gene under the Tet promoter. The chromosomes of tet-AUR1 cells were randomly mutated by insertion of the mTn-lacZ/LEU2 transposon (Burns et al., 1994) , and then mutant cells that can grow in the presence of 10 mg/ml Dox were isolated. Twenty-one colonies were isolated from 20 000 transformants, and the yeast genomic DNA adjacent to the transposon was sequenced to identify genes disrupted by the transposon. The sites of transposon insertion in 14 mutants were determined (Table 1) ; however, the sites of 7 mutants could not be determined due to unknown reason(s). Finally, we identified seven mutations (srb8, ssn3, rfx1, hta1, xrn1, dck1 and ras2) that confer resistance to the AUR1 repression (Table 1) . To confirm the effect of these mutations on the impaired metabolism of sphingolipids, the entire open reading frame of each gene was replaced with the kanMX4 marker. As shown in Fig. 1C , srb8D, ssn3D, rfx1D, hta1D, xrn1D, dck1D and ras2D suppressed the growth defect of Dox-treated tet-AUR1 cells. In addition, the suppressive effect of these mutations was also observed when LCB1 encoding serine palmitoyltransferase was repressed by the Tet promoter (tet-LCB1) ( Fig. 1D ) (Tani and Kuge, 2010a) . We also screened for multicopy suppressor genes that suppress the growth defect of Dox-treated tet-AUR1 cells.
A pool of tet-AUR1 cells was transformed with a yeast genomic library in a high-copy number vector, YEp13, followed by screening for cells exhibiting growth in the presence of 10 mg/ml of Dox. Thirteen colonies were isolated from 70 000 transformants. Plasmids extracted from the isolated clones were re-transformed into tet-AUR1 cells, and resistance to the Dox treatment was confirmed. Finally, we identified one plasmid containing chromosome XIII (341696-349143 bp) that allowed the growth of Doxtreated tet-AUR1 cells (data not shown). This chromosomal region contained one candidate gene, MSN2, which encodes a transcriptional factor involved in various stress responses (Schmitt and McEntee, 1996) . As shown in Fig. 1E , the growth defect of Dox-treated tet-AUR1 cells was suppressed when a multicopy vector (pRS425) containing MSN2 was introduced into the cells. The suppressive effect of the overexpression of MSN2 was also observed when chromosomal MSN2 in tet-AUR1 and tet-LCB1 cells was overexpressed under the control of a constitutive and strong TEF promoter (Fig.  1F) [the overexpression of Msn2 by the TEF promoter was confirmed by tagging with 6xHA at the C-terminus of Msn2 (Supporting Information Fig. S1A) ].
Involvement of Hog1 in suppression of the growth defect caused by impaired biosynthesis of complex sphingolipids SSN3 and SRB8 encode components of the cyclindependent kinase (CDK) module of the mediator complex of RNA polymerase II, and are involved in suppression of activation of several transcriptional factors involved in various stress responses, such as Msn2 (Chi et al., 2001; Nelson et al., 2003; Casamassimi and Napoli, 2007) . We found that the deletion of SSN3 causes increase in the transcriptional activity of Msn2 and Msn4 under the AUR1-repressive conditions (Tani et al., unpublished results) . The Cyc8-Tup1 complex functions as a transcriptional corepressor to repress expression of diverse stress-inducible genes (Smith and Johnson, 2000) , and RFX1 encodes a protein required for recruitment of the Cyc8-Tup1 complex to the target promoter (Huang et al., 1998) . Thus, it was assumed that activation of some stress response pathways can suppress the growth defect caused by the impaired biosynthesis of sphingolipids. This hypothesis is supported by the fact that MSN2 functions as a multicopy suppressor ( Fig. 1E and F) . In addition, DCK1 encodes a guanine nucleotide exchange factor (GEF) for small GTPase Rho5 (Schmitz et al., 2015) , and Rho5 has been suggested to be related to acquisition of resistance to hyperosmotic stress (Annan et al., 2008) . Moreover, it was previously reported that mutation of LCB2 (lcb2-M1) or treatment with myriocin or aureobasidin A (AbA), an inhibitor of SPT or IPC synthase respectively, causes activation of the high-osmolarity glycerol (HOG) pathway, which controls responses to hyperosmotic stress (Brewster and Gustin, 2014) ; however, the physiological significance of the activation remains unclear (Tanigawa et al., 2012) . For the above reasons, we investigated the involvement of the HOG pathway in suppression of the growth defect caused by the impaired biosynthesis of sphingolipids. Initially, HOG1 encoding a mitogen-activated protein kinase (MAPK) in Fig. 2 . Deletion of HOG1 causes hypersensitivity to the growth defect caused by impaired biosynthesis of complex sphingolipids.
A. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. B. Effects of repression of LIP1 on sensitivity to aureobasidin A (AbA). tet-LIP1 and tet-LIP1 hog1D cells were cultured overnight in YPD medium with or without 10 mg/ml Dox and then diluted (0.2 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox and the indicated concentrations of AbA, and then aliquots of cell suspensions were subjected to cell density measurements (A 600 ) at the indicated times. Data represent means 6 SD for one experiment (triplicate) representative of three independent experiments. C. Effect of overexpression of HOG1. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 5 days (for tet-AUR1 cells) or 2 days (for tet-LCB1 cellls). D. Time-courses of cell growth of wild-type, hog1D, tet-AUR1, and tet-AUR1 hog1D cells. Cells were cultured overnight in YPD medium and then diluted (0.1 A 600 units/ml) in fresh YPD medium with or without the indicated concentrations of Dox, and then aliquots of cell suspensions were subjected to cell density measurements (A 600 ) at the indicated times. Data represent means 6 SD for one experiment (triplicate) representative of three independent experiments. E. Phosphorylation of Hog1 by the AUR1 repression. Cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for the indicated times at 308C. Yeast cell extracts were immunoblotted using antiphospho-p38 MAPK, anti-Hog1 or anti-Pgk1. The relative amounts of phospho-Hog1 were determined with ImageJ software. The amount of phospho-Hog1/Hog1 in wild-type cells (3 h) was taken as 1. Data represent means 6 SD for three independent experiments. Statistical analysis was done using Student's t test, and the P values obtained are indicated. The details are given under Experimental Procedures. F, tet-AUR1 hog1D cells harboring pRS415-TEFp-HOG1-yeGFP were cultured overnight in SC-Leu and then diluted (0.1 A 600 units/ml) in fresh SC-Leu with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. The cells were then fixed by 2% paraformaldehyde in PBS (-), stained with DAPI to visualize the nuclei, and viewed under a fluorescence microscopy (Leica DMRB;Leica, Solms, Germany). The arrows indicate nuclear localization of Hog1-yeGFP. The graphs indicate frequency distribution of nuclear fluorescence intensity of yeGFP in individual cells, which was quantified with ImageJ software. Percentage of nuclear yeGFP fluorescence in each individual cell was calculated as follows: nuclear fluorescence in individual cells (%) 5 percentage of nuclear fluorescence in total cellular fluorescence. Data represent the value of 100 cells pooled from three independent experiments for each strain.
the HOG pathway (Brewster and Gustin, 2014) was deleted in tet-AUR1 cells, tet-AUR1 hog1D cells being generated. As shown in Fig. 2A , Dox-treated tet-AUR1 hog1D cells exhibited more severe growth inhibition than Dox-treated tet-AUR1 ones. A similar effect of the deletion of HOG1 was observed when LCB1 was repressed ( Fig. 2A) . The enhancement of the growth defect by the HOG1 deletion was also observed on treatment with AbA or myriocin (described later). Moreover, the deletion of HOG1 or the gene encoding Hog1 upstream kinase Pbs2 enhanced the growth defect in temperaturesensitive mutants of LCB1 (lcb1-100) (Supporting Information Fig. S2A and B) or AUR1 (Funato et al., unpublished results). The repression of AUR1 causes reductions in the complex sphingolipid levels and accumulation of Cers, both of which are responsible for the growth defect caused by the repression (Nagiec et al., 1997) .
It has been reported that cells lacking LAG1 and LAC1 encoding Cer synthases exhibit resistance to AbA because of suppression of Cer accumulation by the inhibitor (Schorling et al., 2001) , and that conversely, overexpression of LAG1 and LAC1 leads to enhanced sensitivity to AbA (Murakami et al., 2015) . Thus, to investigate why HOG1-deleted cells exhibit hypersensitivity to the repression of Aur1, we next examined whether or not the hypersensitivity to AbA of hog1D cells is suppressed by the repression of Cer synthase. To test this, tet-LIP1 cells that carry the LIP1 encoding regulatory subunit of Cer synthase under the control of Tet promoter were used (Vallee and Riezman, 2005; Tani and Kuge, 2010a) . As shown in Fig. 2B , the growth inhibitory effect of 0.02 mg/ml of AbA in tet-LIP1 cells was significantly suppressed by the addition of Dox (tet-LIP1 versus tet-LIP1 1 Dox); however, tet-LIP1 hog1D cells still exhibited a severe growth defect with 0.02 mg/ ml of AbA even in the presence of Dox. Moreover, the combination of the LIP1 repression and the HOG1 deletion greatly enhanced the growth inhibitory effect of a lower concentration of AbA (0.007 mg/ml), indicating that the hypersensitivity to AbA of the HOG1-deleted cells is enhanced by the repression of Cer synthesis (Fig. 2B ). Treatment with a low concentration of myriocin (0.1 mg/ ml), which did not cause a growth defect in wild-type cells, partly rescued the growth defect of Dox-treated tet-AUR1 cells, supporting the notion that inhibition of upstream of Aur1 in the de novo sphingolipid biosynthesis pathway can relieve the growth defect (Supporting Information Fig. S3 ). However, myriocin had no effect on the growth defect of Dox-treated tet-AUR1 hog1D cells (Supporting Information Fig. S3 ). Furthermore, although a notable difference in growth rate between Dox-treated LIP1 and Dox-treated LIP1 hog1D cells was not observed (Fig. 2B ), Dox-treated tet-LIP1 hog1D cells exhibited a severe growth defect in the presence of 0.05 or 0.1 mg/ml of myriocin (Supporting Information Fig.  S4 ). Thus, collectively, these results strongly suggested that the deletion of HOG1 causes hypersensitivity to a decrease in complex sphingolipid biosynthesis.
In contrast to the result of effects of the HOG1 deletion, the growth defect caused by AUR1 or LCB1 repression was slightly suppressed when HOG1 was overexpressed through substitution of the promoter region of chromosomal HOG1 with the TEF promoter (TEFp-HOG1) (Fig.  2C) [the increase in the Hog1 protein expression level caused by the TEF promoter was confirmed by Western blotting (Supporting Information Fig. S1B) ]. The growth defect of the lcb1-100 mutant was also partially rescued by HOG1 overexpression under the control of the GAL promoter (Supporting Information Fig. S2C ).
In liquid culture, the growth rate of tet-AUR1 cells began to slow down 6-9 h after the addition of 0.2 or 10 mg/ml of Dox, and the growth defect was significantly enhanced by the deletion of HOG1 (Fig. 2D ). An increase in the phosphorylation level of Hog1 was clearly observed after Dox treatment for 5 or 8 h (Fig. 2E ). In addition, nuclear localization of Hog1-yeGFP was increased in AUR1-repressed cells (Fig. 2F ), indicating that Hog1 translocates into the nucleus in response to the AUR1 repression. Thus, collectively, these results suggested that repression of Aur1 causes activation of Hog1, and Hog1 is involved in suppression of the growth defect caused by a decrease in complex sphingolipid biosynthesis.
Effect of HOG1 deletion on membrane lipid levels
When cells are treated with myriocin, TOR complex 2-Ypk1/2 signaling upregulates sphingolipid biosynthesis via downregulation of Orm1/2, and this upregulation confers resistance to the inhibitor (Breslow et al., 2010; Roelants et al., 2011) . Thus, it is possible that the activation of Hog1 upregulates sphingolipid-metabolizing enzymes, and consequently confers resistance to the growth defect caused by decreased complex sphingolipid biosynthesis. Thus, we next examined the levels of complex sphingolipids and Cer in HOG1-deleted cells under both AUR1-repressive and -nonrepressive conditions ( Fig. 3A and B) . As reported previously, in tet-AUR1 cells, the Dox treatment caused dramatic reductions in the levels of complex sphingolipids and an increase in the level of Cer-C, the most major type of Cer in yeast ( Fig. 3A and B) (Tani and Kuge, 2010a; Toume and Tani, 2016) . Dox-untreated tet-AUR1 cells exhibited slight decreases in complex sphingolipid levels and an increase in the Cer-C level as compared with wild-type cells, probably because of a partial decrease of IPC synthase activity caused by substitution of the promoter region ( Fig. 3A and B) (Toume and Tani, 2014) . hog1D cells exhibited approximately 10% increases in the complex sphingolipid levels as compared with wild-type cells, and the effect of HOG1 deletion on the complex sphingolipid levels was also observed in tet-AUR1 cells regardless of the presence or absence or Dox (Fig. 3A ). The Cer-C level was not affected by the deletion of HOG1 in either Dox-treated or -untreated tet-AUR1 cells (Fig. 3B ). In addition, the overexpression of HOG1 (TEFp-HOG1) did not affect complex sphingolipid and Cer levels under both AUR1-repressive and -nonrepressive conditions (Supporting Information Fig. S5 ). Thus, it was indicated that loss of Hog1 does not enhance the reductions in complex sphingolipid levels or the increase in the Cer level caused by the AUR1 repression, implying that the suppressive effect of Hog1 on the growth defect caused by the AUR1 repression is not attributed to restoration of impaired biosynthesis of complex sphingolipids.
To investigate whether or not HOG1 deletion affects other classes of membrane lipids, the levels of ergosterol and major glycerophospholipids [phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylethanolamine (PE) and phosphatidic acid (PA)] were examined ( Fig. 3C and D) . The AUR1 repression caused an approximately 25% reduction in the ergosterol level; however, loss of HOG1 did not affect the reduction (Fig. 3C ). The PE and PS levels were significantly reduced by the AUR1 repression (Fig. 3D ). It also has been reported that the reduction of the PE and PS levels is also observed on treatment with AbA (Voynova et al., 2015) . The reduction of the PS level caused by the AUR1 repression was significantly enhanced by the deletion of HOG1 (Fig. 3D , Dox-treated tet-AUR1 cells versus Fig. 3 . TLC analyses of membrane lipids. Wild-type, hog1D, tet-AUR1, and tet-AUR1 hog1D cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. Lipids were extracted, and then separated by TLC. In the complex sphingolipid (A) and Cer-C (B) analyses, the samples were subjected to mild alkaline treatment using MMA before application to a TLC plate. The lipids were visualized with a copper sulfate and orthophosphoric acid reagent. Dox-treated tet-AUR1 hog1D cells). To investigate whether or not the robust reduction in the PS level in AUR1-repressed and HOG1-deleted cells is the cause of the hypersensitivity to the AUR1 repression, chromosomal CHO1 encoding PS synthase was overexpressed under the control of the TEF promoter (TEFp-CHO1), which has been previously shown to increase the cellular PS level (Tani and Kuge, 2010b) . The PS level in Dox-treated tet-AUR1 TEFp-CHO1 hog1D cells was comparable to that in Dox-treated tet-AUR1 cells (Supporting Information Fig.  S6A) ; however, the overexpression of CHO1 did not affect the growth defect of AUR1-repressed hog1D cells (Fig. S6B) , indicating that the hypersensitivity of HOG1-deleted cells to the AUR1 repression is not caused by the enhancement of the reduction in the PS level. Conversely, when AUR1 was repressed, an unidentified band was observed between PE and PS (Fig. 3D) ; however, the physiological significance of the band is unclear.
Involvement of Msn2/4-and Sko1-mediated transcriptional regulation in the suppressive effect of Hog1 on the growth defect of AUR1-repressed cells On hyperosmotic stress, Hog1 upregulates the expression of many genes through direct regulation of several transcriptional regulators including Msn2/4, Sko1, Hot1 and Smp1 (Fig. 4A ) (Brewster and Gustin, 2014) . Thus, we next investigated which transcriptional regulator is involved in the suppressive effect of Hog1 on the growth defect caused by the AUR1 repression. Deletion of MSN2 enhanced the growth defect caused by the AUR1 repression (Dox-treated tet-AUR1 cells versus tet-AUR1 msn2D cells) (Fig. 4B) . Although deletion of MSN4 alone did not have a significant effect on the growth defect caused by the AUR1 repression, tet-AUR1 msn2D msn4D cells were more sensitive to Dox as compared with tet-AUR1 msn2D cells, indicating that both Msn2 and Msn4 are involved in the suppression of the growth defect. Msn2/4 bind to promoters containing the stress response element (STRE) (Schmitt and McEntee, 1996) . To investigate whether or not Msn2/4-mediated transcriptional activation occurs in AUR1-repressed cells in a Hog1-dependent manner, a reporter gene plasmid, which contains 7xSTRE and the a-galactosidase gene (pRS416-7xSTRE-MEL1 constructed in this study), was introduced into cells. As shown in Fig. 4C , Dox-treated tet-AUR1 cells exhibited an approximately 1.3-fold increase in a-galactosidase activity as compared with wild-type and Dox-treated wild-type cells when cells were treated with Dox for 5 or 8 h, indicating that the repression of AUR1 causes an increase in the activity of STRE. The deletion of MSN2 and MSN4 caused a dramatic reduction in the activity of a-galactosidase, indicating that the reporter gene assay detects Msn2/4-dependent transcriptional activation (Fig. 4D) . Moreover, the increase in STRE activity caused by the AUR1 repression was cancelled by the deletion of HOG1 (Fig. 4D) , indicating that the transcriptional activation via Msn2/4 is mediated by Hog1.
Deletion of SKO1 did not significantly change the sensitivity of tet-AUR1 cells to Dox (Dox-treated tet-AUR1 cells versus Dox-treated tet-AUR1 sko1D cells) (Fig. 4B ). In the absence of stresses including hyperosmotic stress, Sko1 functions as a transcriptional repressor that regulates expression of a subset of genes induced by the HOG pathway, and thus, the deletion of SKO1 causes increases in the expression levels of such stress-inducible genes even in the absence of Hog1 (Proft et al., 2001) . Thus, we created tet-AUR1 hog1D sko1D cells. In the presence of Dox, the deletion of SKO1 alleviated the growth defect of tet-AUR1 hog1D cells (Dox-treated tet-AUR1 hog1D cells versus Dox-treated tet-AUR1 hog1D sko1D cells) (Fig. 4B) , indicating that the loss of Sko1 can suppress the hypersensitivity of HOG1-deleted cells to the AUR1 repression. The Cyc8-Tup1 corepressor complex is essential for the repressor activity of Sko1 (Proft et al., 2001; Proft and Struhl, 2002) , and we found that deletion of CYC8 also caused suppression of the hypersensitivity of HOG1-deleted cells to the AUR1 repression (Fig. 4B , tet-AUR1 hog1D cyc8D cells). To investigate whether or not Sko1-mediated transcriptional regulation occurs in the AUR1-repressed cells in a Hog1-dependent manner, a reporter gene plasmid, which contains a potential promoter region of GRE2, a Sko1-regulated gene (Proft et al., 2001; Proft and Struhl, 2002) , and a-galactosidase gene (pRS416-GRE2-MEL1), was constructed. tet-AUR1 cells treated with Dox for 8 h, but not 5 h, exhibited an approximately 2.6-fold increase in the activity of the GRE2 promoter. The   Fig. 4 . Msn2/4-and Sko1-mediated transcriptional regulation is involved in the suppressive effect of Hog1 on the growth defect caused by the AUR1 repression. A. Schematic diagram of the HOG pathway in S. cerevisiae. The activation of Hog1 directly regulates several transcriptional regulators including Msn2/4, Sko1, Hot1 and Smp1. Sko1 functions as a transcriptional repressor when the HOG pathway is not activated; however, once Hog1 is activated, the gene expression under the control of Sko1 is activated. B. Effects of deletion of transcriptional regulators on the growth defect caused by the AUR1 repression. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. C. STRE-mediated transcriptional activation under the AUR1-repressive conditions. Cells harboring pRS416-7xSTRE-MEL1 were cultured overnight in SC medium lacking uracil (SC-Ura), diluted (0.1 A 600 units/ml) in fresh SC-Ura with or without 10 mg/ml Dox, and then incubated for 5 or 8 h at 308C. Cells were harvested and a-galactosidase activity was measured as described under Experimental Procedures. The activity of wild-type cells (5 h) was taken as 1. D. Hog1 dependency of activation of STRE. Cells were treated with 10 mg/ml Dox for 8 h at 308C, and then a-galactosidase activity was measured. E, activation of the GRE2 promoter under the AUR1-repressive conditions. Cells harboring pRS416-GRE2p-MEL1 were cultured overnight in SC-Ura, diluted (0.1 A 600 units/ml) in fresh SC-Ura with or without 10 mg/ml Dox, and then incubated for 5 or 8 h at 308C. Cells were harvested, and then a-galactosidase activity was measured. The activity in wild-type cells (5 h) was taken as 1. F, Hog1 dependency of activation of the GRE2 promoter. Cells were treated with 10 mg/ml Dox for 8 h at 308C, and then a-galactosidase activity was measured. Data represent means 6 SD for one experiment (triplicate) representative of three independent experiments. The details are given under Experimental Procedures. Statistical analysis was done using Student's t test, and the P values obtained are indicated.
increase was cancelled by the deletion of HOG1, indicating that the activation of the GRE2 promoter is mediated through Hog1. Notably, the deletion of SKO1 caused an approximately eightfold increase in the activity of the GRE2 promoter, and the increase was not cancelled by the deletion of HOG1 (Fig. 4F ). This may explain why the deletion of SKO1 partly rescues the hypersensitivity of HOG1-deleted cells to the AUR1 repression. Similar results were obtained when transcriptional activity under the control of Sko1 was examined with the 8xCRE-lacZ reporter gene (a kind gift from Dr. Kazuo Tatebayashi, Tokyo University), which is used as a HOG pathwayspecific reporter (Tatebayashi et al., 2006) (Supporting Information Fig. S7 ). In contrast, deletion of SMP1 or HOT1 did not affect the growth defect caused by the AUR1 repression (Fig. 4B ). Hot1 and Msn1 are coordinately involved in upregulation of transcription under hyperosmotic stress (Rep et al., 1999) ; however, no difference in the growth defect was observed between Dox-treated tet-AUR1 and Dox-treated tet-AUR1 hot1D msn1D cells (Fig. 4B) . Thus, collectively, Msn2/4 and Sko1, but not Smp1 and Hot1, are involved in the suppressive effect of Hog1 on the growth defect caused by the AUR1 repression. Similar effects of deletion of each transcriptional regulator were observed under the LCB1-repressive conditions (Supporting Information Fig. S8 ).
Deletion of HOG1 or MSN2/4 enhances the aberrant ROS accumulation caused by the AUR1 repression
The transcriptional regulation via Msn2/4 and Sko1 is involved in activation of gene expression required for adaptation to various environmental changes, which is known as a 'general stress response' (Capaldi et al., 2008) . The activation of the general stress response induces increases in the expression levels of a lot of genes, encoding chaperones, proteins involved in energy metabolism, detoxication of reactive oxygen species (ROS), cellular redox reactions, cell wall modification, and DNA damage repair. It has been reported that ROS levels are increased by the impaired biosynthesis of sphingolipids (Kajiwara et al., 2012; Niles et al., 2014) . Thus, we next examined whether or not the deletion of HOG1 affects the accumulation of ROS by the AUR1 repression. As shown in Fig. 5A , increases in ROS levels caused by the AUR1 repression were enhanced on the deletion of HOG1 or MSN2 and MSN4 (Dox-treated tet-AUR1 cells versus Doxtreated tet-AUR1 hog1D or Dox-treated tet-AUR1 msn2D msn4D cells). Conversely, when MSN2 was overexpressed, the accumulation of ROS by the AUR1 repression was decreased (Dox-treated tet-AUR1 cells versus Dox-treated tet-AUR1 TEFp-MSN2 cells) (Fig.   5A ). Thus, these results suggested that loss of the HOG pathway or Msn2/4-mediated transcriptional activation enhances the aberrant ROS accumulation caused by the AUR1 repression. We also examined whether or not the membrane-permeating antioxidant N-acetylcysteine (NAC) can improve the growth of tet-AUR1, tet-AUR1 hog1D, tet-AUR1 msn2D msn4D cells in the presence of Dox. As shown in Fig. 5B , the growth of Dox-treated tet-AUR1 and Dox-treated tet-AUR1 msn2D msn4D cells was slightly improved in the presence of 20 mM NAC; however, the extent of the growth of Dox-treated tet-AUR1 msn2D msn4D cells was still lower than that of Dox-treated tet-AUR1 cells. On the contrary, the growth defect of Dox-treated tet-AUR1 hog1D cells was not changed by the addition of NAC (Fig. 5B) . The efficiency of NAC was confirmed by antagonization of the toxic effect of hydrogen peroxide and ROS-generating oxidant paraquat in wild-type cells (Fig. 5C ). We also tested whether or not overexpression of CTT1 encoding cytosolic catalase, SOD1 encoding cytosolic and mitochondrial intermembrane space superoxide dismutase, or SOD2 encoding mitochondrial superoxide dismutase can improve the growth defect of the AUR1-repressed cells; however, they had no effect on the growth of Dox-treated tet-AUR1, Dox-treated tet-AUR1 hog1D and Dox-treated tet-AUR1 msn2D msn4D cells (data not shown). Thus, it is likely that the suppressive effect of the HOG pathway on the growth defect caused by the AUR1 repression is not induced by suppression of the oxidative stress only, but may be attributed to composite factors included in the general stress response. DNA microarray analysis revealed that approximately 200 of the genes were upregulated under the AUR1-repressive conditions, and among them, approximately 80 of the genes were increased in a Hog1-dependent manner (Tani M et al., unpublished results) . The genes upregulated under the AUR1-repressive conditions included 34 genes that are induced by diverse environmental stress response (Gasch et al., 2000) . Notably, among the 34 genes, 20 genes were upregulated in a Hog1-dependent manner. These results support the notion that the suppressive effect of HOG pathway on the growth defect caused by the AUR1 repression is attributed to multiple factors.
Contribution of Sln1 and Sho1 branches of the HOG pathway to suppression of the growth defect caused by AUR1 repression Hog1 is activated via two independent branches, the Sln1 and Sho1 branches (Brewster and Gustin, 2014) (Fig. 4A) . To investigate which branch is important for suppression of the growth defect caused by the AUR1 repression, genes that constitute the Sln1 branch (SSK1, SSK2 and SSK22) or Sho1 branch (SHO1 and STE11) were deleted in tet-AUR1 cells. As shown in Fig. 6A , Dox-treated tet-AUR1 ssk1D and Dox-treated tet-AUR1 ssk2D cells exhibited a more severe growth defect than Dox-treated tet-AUR1 cells; however the deletion of SSK22 had no effect on the growth defect A. Visualization of ROS by H 2 DCFDA staining. Cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for 7 h at 308C. The cells were stained with 10 mM H 2 DCFDA for 1 h at 308C. The cells were collected by centrifugation and viewed under a fluorescence microscope. The graphs indicate frequency distribution of H 2 DCFDA fluorescence intensity in individual cells. The fluorescence intensity was quantified with ImageJ software. Data represent the value for 100 cells for each strain. B. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without 20 mM NAC and the indicated concentration of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 or 3 days. C. Effects of NAC on H 2 O 2 and paraquat sensitivities. Cells were spotted onto YPD plates with or without 20 mM NAC, 6 mM H 2 O 2 or 2 mM paraquat, incubated at 308C, and then photographed after 2 days.
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caused by the AUR1 repression. Moreover, the deletion of SSK1 or SSK2, but not SSK22, strongly inhibited the increases in both GRE2 promoter activity and Hog1 phosphorylation caused by the AUR1 repression ( Fig.  6B and Supporting Information Fig. S9 ). Thus, it was indicated that under the AUR1-repressive conditions, Ssk2, but not Ssk22, plays a pivotal role as a MAPKKK in the Sln1 branch. In contrast, the deletion of components of the Sho1 branch (sho1D and ste11D) did not affect the growth defect or GRE2 promoter activation under the AUR1-repressive conditions ( Fig. 6A and B) . It should be noted that the growth defects in Dox-treated tet-AUR1 ssk1D, Dox-treated tet-AUR1 ssk2D and Doxtreated tet-AUR1 ssk2D ssk22D cells were less severe than that in Dox-treated tet-AUR1 hog1D cells; however, the effect of triple deletion of SSK2, SSK22 and STE11 on the growth defect under the AUR1-repressive conditions was comparable with that of HOG1 deletion (Fig.  6A) , suggesting that the Sho1 branch plays a minor role in the suppression of the growth defect caused by the AUR1 repression. We also examined the effect of overexpression of SSK1 on the AUR1 repression. To do this, a CEN-based plasmid (pRS415) harboring 3xHA-tagged SSK1 with the TEF promoter was expressed in tet-AUR1 ssk1D cells (Fig. 6C ). As shown in Fig. 6D , the overexpression of 3xHA-SSK1 caused resistance to the AUR1 repression, and the suppressive effect of overexpression of the constitutive active form of 3xHA-Ssk1 [Ssk1-D554N (Horie et al., 2008) ] was slightly more potent than that of 3xHA-Ssk1 [the expression level of 3xHA-Ssk1-D554N was comparable to that of 3xHA-Ssk1 (Fig. 6C)] .
It was previously reported that the activation of Hog1 caused by a point mutation in SPT is mediated through both the Sln1 and Sho1 branches (Tanigawa et al., 2012) . Thus, we examined the involvement of each branch in the suppression of the growth defect when aberrant metabolism of sphingolipids was induced in several different ways, including repression of LCB1 by the Tet promoter (tet-LCB1), and treatment with AbA or myriocin (Fig. 6E) . The deletion of SSK2, but not SSK22 or SHO1 enhanced the growth defect of Dox-treated tet-LCB1 cells (Fig. 6E) . The deletion of SSK2, SSK22, or SHO1 caused hypersensitivity to AbA and myriocin; however, the sensitivities of ssk2D cells were much more severe than those of ssk22D and sho1D cells (Fig.  6E) . Thus, it was indicated that both the Sln1 and Sho1 branches are required for the suppression of the growth defect caused by the impaired biosynthesis of sphingolipids, but that the Sln1 branch via Ssk2 is preferentially involved in the suppression (Fig. 6F) .
Small GTPase Rho5 is involved in suppression of activation of the HOG pathway caused by AUR1 repression
The transposon mutagenesis screening revealed that the deletion of DCK1 that encodes a guanine nucleotide exchange factor (GEF) for Rho5 (Schmitz et al., 2015) confers resistance to the AUR1 or LCB1 repression ( Fig. 1C and D) . As shown in Fig. 7A , deletion of RHO5 or LMO1 encoding a protein required for the GEF function of Dck1 (Schmitz et al., 2015) conferred resistance to the AUR1 repression. In contrast, overexpression of the chromosomal RHO5 by the TEF promoter (TEFp-RHO5) resulted in hypersensitivity to the AUR1 repression (Fig. 7B ) (the overexpression of Rho5 by the TEF promoter was confirmed by tagging with 3xFLAG at the N-terminus of Rho5 (Supporting Information Fig. S1C ). It was previously reported that Rho5 physically interacts with Ste50, which functions as an adaptor protein of Ste11 MAPKKK, and the combination of expression of the constitutive active form of Rho5 and deletion of Ste11 causes hypersensitivity to hyperosmotic stress (Annan et al., 2008) ; however, it has remained unclear whether or not Rho5 regulates the HOG pathway. Thus, we next investigated the role of Rho5 in regulation of the HOG pathway under the impaired biosynthesis of complex sphingolipids. As shown in Fig. 7C , the resistance to the AUR1 repression in the RHO5-deleted cells was greatly suppressed by the deletion of HOG1 (Doxtreated tet-AUR1 rho5D cells versus Dox-treated tet-AUR1 hog1D rho5D cells); however, the growth defect of Dox-treated tet-AUR1 hog1D rho5D cells was not severer than that of Dox-treated tet-AUR1 hog1D cells, suggesting that the resistance to the AUR1 repression caused by the deletion of RHO5 is acquired in both Hog1-dependent and -independent manners. To assess the involvement of Rho5 in the activation of the HOG pathway under the AUR1-repressive conditions, the A. Effects of deletion of upstream factors of Hog1 on the AUR1 repression. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. B. Activation of the GRE2 promoter. Cells harboring pRS416-GRE2p-MEL1 were cultured overnight in SC-Ura, diluted (0.1 A 600 units/ml) in fresh SC-Ura with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. Cells were harvested, and then a-galactosidase activity was measured. The activity of wild-type cells was taken as 1. C. Expression of 3xHA tagged Ssk1. Cells harboring pRS415-TEFp-3xHA-SSK1, pRS415-TEFp-3xHA-SSK1-D554N or the empty plasmid were cultured overnight in SC-Leu, diluted (0.2 A 600 units/ml) in fresh SC-Leu, and then incubated for 6 h at 308C. Yeast cell extracts were immunoblotted using anti-HA or anti-Pgk1. D. Cells harboring pRS415-TEFp-3xHA-SSK1, pRS415-TEFp-3xHA-SSK1-D554N or the empty plasmid were cultured in SC-Leu, and then spotted onto SC-Leu plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ ml. Plates were incubated at 308C and photographed after 3 days. E. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox, AbA or myriocin in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. The details are given under Experimental Procedures. F. Schematic diagram of the activation of the HOG pathway under the impaired biosynthesis of complex sphingolipids. Both the Sln1 and Sho1 branches are required for the suppression of the growth defect caused by the inhibition of sphingolipid biosynthesis, but the Sln1 branch via Ssk2 is preferentially involved in the suppression. phosphorylation state of Hog1 (Fig. 7D) , and the activation of STRE and the GRE2 promoter ( Fig. 7E and F) were examined. In the absence of Dox, tet-AUR1 rho5D cells exhibited an increase in the phosphorylation level of Hog1, and the activities of STRE and the GRE2 promoter as compared with tet-AUR1 cells (Fig. 7D-F) ; however, significant differences in the activities of STRE and GRE2 promoter were not observed between wildtype and rho5D cells (Fig. 7E and F) . Since introduction of tet-AUR1 into cells causes partial reduction of complex sphingolipid levels even in the absence of Dox (Fig.  3A ) (Toume and Tani, 2014) , it is likely that the HOG pathway is more easily activated on the reduction in complex sphingolipid biosynthesis when Rho5 is absent. In addition, in the presence of Dox, the deletion of RHO5 significantly increased the activities of STRE and the GRE2 promoter ( Fig. 7E and F) . In contrast, the overexpression of RHO5 caused reductions in the phosphorylation level of Hog1, and the activities of STRE and the GRE2 promoter in the presence of Dox (Fig.  7D-F) . Under the AUR1-repressive conditions, the enhancement of the activation of STRE and the GRE2 promoter in the RHO5-deleted cells was markedly suppressed by the deletion of HOG1 or SSK2, but not SHO1 (Fig. 7G and H) . Thus, these results indicated that Rho5 negatively regulates the Ssk2-mediated HOG pathway when complex sphingolipid biosynthesis is compromised.
Hog1 is involved in suppression of the growth defect caused by insufficient biosynthesis of ergosterol but not glycerophospholipids
We next investigated whether or not the HOG pathway plays a protective role to the growth defect caused by aberrant metabolism of other membrane lipids including ergosterol and glycerophospholipids, as well as complex sphingolipids. To reduce the cellular ergosterol levels, we created a mutant strain in which the expression of ERG9 encoding squalene synthase is repressed in the presence of Dox (tet-ERG9) (Fig. 8A) . The ergosterol level in Dox-treated tet-ERG9 cells was reduced by approximately 50% as compared with those in wild-type and Dox-untreated tet-ERG9 cells (Supporting Information Fig. S10 ). Dox-treated tet-ERG9 cells exhibited only a mild growth defect as compared with Dox-untreated ones, and the deletion of HOG1 slightly enhanced the growth defect (Fig. 8C) . The growth inhibitory activities of imidazoles and triazoles, which act as inhibitors of ergosterol biosynthesis, are enhanced by deletion of ERG6 encoding C-24-D-sterol-methyltransferase (Kodedova and Sychrova, 2015) ; thus, to more clearly observe the effect of the ergosterol biosynthesis defect, tet-ERG9 erg6D and tet-ERG9 erg6D hog1D cells were created. The growth defect of Dox-treated tet-ERG9 erg6D hog1D cells was much more severe than that of Dox-treated tet-ERG9 erg6D cells (Fig. 8C) , suggesting that HOG1-deleted mutants are very sensitive to the defect of the ergosterol biosynthesis. Dox-treated anduntreated tet-ERG9 erg6D cells exhibited increase in the phosphorylation level of Hog1 as compared with wildtype cells when cells were cultured overnight, diluted (0.1 A 600 units/ml) in a fresh medium, and then incubated for 3 h (Fig. 8D) . Similarly, it has been reported that the phosphorylation level of Hog1 is increased in erg6D cells (Tanigawa et al., 2012) . We next investigated whether or not HOG1 deletion affects the level of sterols in tet-ERG9 erg6D cells. In tet-ERG9 erg6D cells, the sterol band, which corresponds to R f value of ergosterol, was significantly decreased by the Dox treatment; however significant difference between Doxtreated tet-ERG9 erg6D and Dox-treated tet-ERG9 erg6D hog1D cells was not observed (Fig. 8E) . Thus, it was indicated that the deletion of HOG1 does not affect the reductions in sterol levels under the ergosterol biosynthesis-repressive conditions. Similar to the AUR1-repressed cells (Fig. 6D) , the growth defect of Doxtreated tet-ERG9 erg6D cells was partly suppressed by the overexpression of the constitutive active form of 3xHA-Ssk1 (3xHA-Ssk1-D554N) (Fig. 8F) .
In yeast, glycerophospholipids, PE and PC, are essential for cell growth, because double deletion of PSD1 and PSD2 encoding PS decarboxylase genes or CHO2 and OPI3 encoding phospholipid methyltransferase genes causes a lethal phenotype, when ethanolamine or choline, which are converted to PE and PC Fig. 7 . Involvement of Rho5 in suppression of the Ssk2-mediated HOG pathway in AUR1-repressed cells.
A. Loss of Rho5 or its GEF confers resistance to the AUR1 repression. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. B. Overexpression of RHO5 causes hypersensitivity to the AUR1 repression. C. Effect of double deletion of Rho5 and Hog1 on the growth defect caused by the AUR1 repression. D, phosphorylation of Hog1. Cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. Yeast cell extracts were immunoblotted using anti-phospho-p38 MAPK, anti-Hog1 or anti-Pgk1. The relative amounts of phosphoHog1 were determined with ImageJ software. The amount of phospho-Hog1/Hog1 in wild-type cells was taken as 1. Data represent means 6 SD for three independent experiments. E and F. Effects of deletion and overexpression of RHO5 on activation of STRE (E) and the GRE2 promoter (F) under the AUR1-repressive conditions. Cells harboring pRS416-7xSTRE-MEL1 (E) or pRS416-GRE2p-MEL1 (F) were cultured overnight in SC medium lacking uracil (SC-Ura), diluted (0.1 A 600 units/ml) in fresh SC-Ura with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. Cells were harvested, and then a-galactosidase activity was measured as described under Experimental Procedures. The activity of wild-type cells was taken as 1. G and H. Increases in the activities of STRE and the GRE2 promoter caused by the deletion of RHO5 under the AUR1-repressive conditions is cancelled by the deletion of SSK2. Data represent means 6 SD for one experiment (triplicate) representative of three independent experiments. The details are given under Experimental Procedures. Statistical analysis was done using Student's t test, and the P values obtained are indicated.
Role of HOG pathway under sphingolipid disruption 377 respectively, via the Kennedy pathway, is absent from the medium (Henry et al., 2012) (Fig. 8B) . As shown in Fig. 8G , the growth of psd1D psd2D cells was delayed when the concentration of ethanolamine in SC medium was gradually reduced, and the growth defect of psd1D psd2D hog1D cells was indistinguishable from that of psd1D psd2D cells. Similarly, differences in the growth defect between cho2D opi3D and cho2D opi3D hog1D cells with the reduced concentrations of choline were not observed (Fig. 8H) . These results indicated that the growth defect caused by a defect of PE and/or PC is not suppressed by the HOG pathway.
Discussion
Although it has been reported that the HOG pathway is activated on inhibition of sphingolipid biosynthesis (Tanigawa et al., 2012) , its physiological importance remains unclear. In this study, we showed that the deletion of HOG1 causes enhancement of the growth defect caused by repression of AUR1 or LCB1. The repression of these sphingolipid-metabolizing enzymes causes reductions in complex sphingolipids, and it was indicated that the HOG pathway plays an important role in suppression of the growth defect caused by impaired biosynthesis of complex sphingolipids. The functional relationship between aberrant metabolism of sphingolipids and the activation of the HOG pathway was also reported in yeast cells with ISC1 encoding inositol phosphosphingolipid phospholipase C deleted; that is, isc1D cells exhibit an increase in the phosphorylation level of Hog1, and mitochondrial dysfunction phenotypes in isc1D cells are mediated via Hog1, implying that the activation of the HOG pathway is deleterious for isc1D cells (Barbosa et al., 2012) . It is believed that, in the absence of stress, constitutive activation of the HOG pathway is toxic for cells because deletion of Sln1 or Ypd1, each of which causes accumulation of nonphosphorylated Ssk1 and subsequent constitutive activation of Hog1, results in a lethal phenotype (Horie et al., 2008) . Thus, it is believed that deletion of ISC1 causes misregulation of the HOG pathway and subsequent mitochondrial dysfunctions. However, the activation of Hog1 caused by the repression of AUR1 plays a role in suppression of the growth defect, and thus it is suggested that the activation is one of the protective responses to confer resistance against the impaired biosynthesis of complex sphingolipids.
Several lines of evidence have indicated the presence of homeostatic regulation systems for cellular sphingolipid levels for acquiring resistance to impaired biosynthesis of sphingolipids. For example, TORC2/Ypk1-mediated signaling is involved in upregulation of SPT and Cer synthase activities when cells are treated with myriocin (Breslow et al., 2010; Roelants et al., 2011; Muir et al., 2014) . In the presence of myriocin, cell cycle checkpoint kinase Swe1 is also involved in maintenance of SPT activity through the phosphorylation of Orm1 and Orm2 (Chauhan et al., 2016) . In addition, accumulation of an excess amount of serine, a precursor of LCBs, in cells causes upregulation of sphingolipid biosynthesis, and expression of CHA1 encoding serine deamidase/dehydratase is subsequently upregulated via Pkh1 and Pkh2 kinases, which are activated by the accumulated LCBs, and involved in suppression of increases in LCBs (Montefusco et al., 2012) . In contrast, however, the HOG pathway seems not to be involved in restoration of sphingolipid biosynthesis under the AUR1-repressive conditions, because the deletion of HOG1 did not exacerbate the changes of sphingolipid levels caused by the AUR1 repression, which include reduction in complex sphingolipid levels and accumulation of Cer (Fig. 3A and B) . On the contrary, the levels of complex sphingolipids in HOG1-deleted cells were slightly but significantly increased as compared with those in HOG1 cells under both AUR1-repressive and -nonrepressive conditions ( Fig. 3A and B) . It should be noted that the increases in sphingolipid levels in HOG1-deleted cells were also revealed on systematic lipidomic analysis (da Silveira Dos Santos et al., 2014). It remains unclear as to how and why complex sphingolipid levels are increased in HOG1-deleted cells, it is possible that sphingolipid biosynthesis is upregulated due to the loss of the complementation system for the cell growth defect caused by the Fig. 8. Effects of the deletion of HOG1 under impaired biosynthesis of ergosterol or glycreophophospholipids. A. Post-farnesyl diphosphate ergosterol biosynthesis pathway in S. cerevisiae. Proteins responsible for the synthesis are shown. B. Biosynthesis pathway of glycerophospholipids (PS, PE, PC and PI) in S. cerevisiae. C. Effects of the deletion of HOG1 under insufficient biosynthesis of ergosterol. Cells were cultured overnight in YPD medium, and then spotted onto YPD plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. D. Phosphorylation of Hog1 in tet-ERG9 erg6D cells. Cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for the indicated times at 308C. Yeast cell extracts were immunoblotted using antiphospho-p38 MAPK, anti-Hog1 or anti-Pgk1. The relative amounts of phospho-Hog1 were determined with ImageJ software. The amount of phospho-Hog1/Hog1 in wild-type cells (3 h) was taken as 1. Data represent means 6 SD for three independent experiments. Statistical analysis was done using Student's t test, and the P values obtained are indicated. E. The sterol levels in tet-ERG9 erg6D and tet-ERG9 erg6D hog1D cells. Cells were cultured overnight in YPD medium, diluted (0.1 A 600 units/ml) in fresh YPD medium with or without 10 mg/ml Dox, and then incubated for 8 h at 308C. Lipids were extracted, and then analyzed by TLC. Sterol band corresponding to R f value of ergosterol were quantified with ImageJ software. The amounts of ergosterol in wild-type cells were taken as 1. Data represent means 6 SD for one experiment (triplicate) representative of three independent experiments. Statistical analysis was done using Student's t test. NS: no significant difference. F. tet-ERG9 erg6D cells harboring pRS415-TEFp-3xHA-SSK1-D554N or the empty plasmid were cultured in SC-Leu, and then spotted onto SC-Leu plates with or without the indicated concentrations of Dox in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ml. Plates were incubated at 308C and photographed after 2 days. G and H, effects of the deletion of HOG1 on the growth defect caused by impaired biosynthesis of PE and/or PC. Cells were cultured overnight in YPD medium, washed two times with water, and then spotted onto SC plates with or without the indicated concentrations of ethanolamine (G) or choline (H) in 10-fold serial dilutions starting with a density of 0.7 A 600 U/ ml. Plates were incubated at 308C and photographed after 2 days. impaired biosynthesis of complex sphingolipids. Several signal transduction pathways, including TORC1, Npr1, TORC2, Ypk1 and Sch9, are involved in regulation of the complex sphingolipid biosynthesis pathway (Roelants et al., 2011; Shimobayashi et al., 2013; Swinnen et al., 2014) . Thus, in future studies, it is important to elucidate which pathway(s) is related to the increases in complex sphingolipid levels due to loss of the HOG pathway.
It was found that both the Sln1 and Sho1 branches are required for the suppression of the growth defect caused by the impaired biosynthesis of sphingolipids, but the Sln1 branch via Ssk2 is preferentially involved in the suppression (Fig. 6) . Several lines of evidence indicated that the Sln1 and Sho1 branches have different response characteristics for stressful conditions that induce activation of Hog1. For example, Ssk1, but not Sho1, is required for ER stress-or glucose starvation-induced activation of Hog1 (Bicknell et al., 2010; Vallejo et al., 2015) . Under hyperosmotic stresses, both the Sln1 and Sho1 branches are involved in the activation of Hog1; however, the Sln1 branch, but not the Sho1 branch, is activated by a low concentration of NaCl, indicating that the Sln1 branch is more easily activated by mild hyperosmotic stress than the Sho1 branch (Maeda et al., 1995) . The increase in the phosphorylation level of Hog1 with the repression of SPT activity is much lower than that with hyperosmotic stress (Tanigawa et al., 2012) . In addition, the repression of AUR1 did not confer increased resistance to hyperosmotic stress (data not shown). Thus, it is likely that the impaired biosynthesis of sphingolipids is a mild stress for induction of activation of the HOG pathway, and this is the reason why the Sln1 branch is preferentially involved in the suppression of the growth defect caused by the impaired biosynthesis of sphingolipids.
It was suggested that the Ssk2-mediated HOG pathway is easily activated by a mild change of complex sphingolipid metabolism when RHO5 is absent (Figs. 7 and 3A) . Generally, constitutive activation of the HOG pathway is toxic for cells in the absence of stress, and thus, it is likely that Rho5 is involved in suppression of excess activation of the HOG pathway under the impaired biosynthesis of complex sphingolipids and maintains its appropriate activity level. The precise molecular mechanism as to how Rho5 regulates the Ssk2-mediated HOG pathway still remains unclear. It was previously reported that Rho5 physically interacts with Ste50, an adaptor protein of Ste11 (Annan et al., 2008) ; however, the fact that expression of the constitutive active form of Rho5 causes hypersensitivity to hyperosmotic stress in the absence of Ste50 (Annan et al., 2008) may implicate that Rho5 targets component(s) of the HOG pathway other than Ste50 for the suppression of the signaling pathway under hyperosmotic stress. Another possibility is that the binding of Rho5 to Ste50 is involved in the suppression of the Ssk2-mediated HOG pathway, even though Ste50 is required for hyperosmotic stress-induced activation of Ste11 (Posas et al., 1998; Wu et al., 2006) . Conversely, it appears that under the AUR1-repressive conditions, Rho5 also has additional function(s) other than the suppression of the HOG pathway, because the growth defect of AUR1-repressed hog1D rho5D cells is less severe than that of AUR1-repressed hog1D cells (Fig.  7C) , implying that the deletion of RHO5 has a suppressive effect on the growth defect even in the absence of Hog1. It has been reported that Rho5 is required for H 2 O 2 -induced cell death and is involved in downregulation of the cell wall integrity pathway (Schmitz et al., 2002; Singh et al., 2008) . To determine whether or not these functions of Rho5 affect the growth defect caused by the impaired biosynthesis of complex sphingolipids, further analyses are required in the future.
The HOG pathway also has a suppressive effect on the growth defect caused by impaired biosynthesis of ergosterol but not that of PC or PE (Fig. 8) . Since complex sphingolipids, together with ergosterol, form lipid microdomains (Simons and Sampaio, 2011) , it is possible that the HOG pathway is involved in complementation of the functional defects caused by impaired formation of lipid microdomains. Since Sln1 and Sho1 are partly localized in lipid microdomain-enriched detergent-resistant membranes (DRMs) (Tanigawa et al., 2012) , it is possible that these sensor proteins recognize the impaired formation of lipid microdomains and contribute to the protection of cells from impaired complex sphingolipid biosynthesis. It should be noted that exogenously added C2-phytoCer perturbs lipid microdomains, and that the Hog1 has a suppressive role to the toxic effect of C2-phytoCer (Pacheco et al., 2013) , supporting the notion of contribution of the HOG pathway to complementation of the functional defects caused by impaired formation of lipid microdomains.
In summary, this study indicated that the HOG pathway and its downstream transcriptional regulation via Msn2/4 and Sko1 play important roles in the suppression of the growth defect caused by the impaired biosynthesis of complex sphingolipids. Further detailed investigation of this molecular mechanism will provide new insights into complementation systems against defects of sphingolipid biosynthesis.
Experimental procedures

Yeast strains and media
The S. cerevisiae strains used are listed in Table 2 . Disruption of genes was performed by replacing their open reading frames with the kanMX4 marker from a genome from a yeast knockout library or the pFA6a-kanMX4 vector, the hphNT1 marker from the pFA6a-hphNT1 vector, the natNT2 marker from the pFA6a-natNT2 vector (Wach et al., 1994; Janke et al., 2004) , the natMX4 marker from the p4339 vector (pCRII-TOPO::natMX4) (Tong and Boone, 2006) , or the URA3 marker from pRS406 (Sikorski and Hieter, 1989) . Occasionally, kanMX4 and natMX4 were replaced with the hygromycin B-resistant gene (from the pFA6a-hphNT1 vector) to create hphMX4. For overexpression of genes by a strong and constitutive TEF promoter, a TEF promoter cassette with the natNT2 marker from pYM-N19 was introduced immediately upstream of the initiator ATG of the chromosomal gene, as described previously (Janke et al., 2004) . The cells were cultured in YPD medium (1% yeast extract, 2% peptone and 2% glucose), SC (synthetic complete) medium (0.67% yeast nitrogen base without amino acids (BD Difco, Heidelberg, Germany) and 2% glucose) containing nutritional supplements, or SC/MSG medium (0.17% yeast nitrogen base without amino acids and ammonium sulfate (BD Difco, Heidelberg, Germany), 0.1% L-glutamic acid sodium salt hydrate (MSG; Sigma) and 2% glucose) containing nutritional supplements.
Plasmid
A multicopy plasmid [pRS425 (Christianson et al., 1992) ] containing MSN2 and its 5 0 -and 3 0 -untranlated regions (520 and 406 bp respectively) was constructed as described below. A DNA fragment was amplified by PCR using a 5 0 primer with a PstI site (5 0 -CCCCTGCAGCC-GAAAATATATACAATTTCCCC-3 0 ), a 3 0 primer with a BamHI site (5 0 -CGCGGATCCCACCCCTCTTGCTTTTGTACG-3 0 ) and yeast genomic DNA as a template. The fragment obtained was subcloned into pRS425.pRS415-TEFp-HOG1-yeGFP, a plasmid expressing a yeast-enhanced green fluorescent protein (yeGFP)-fused Hog1 (Hog1-yeGFP) under the control of TEF promoter was constructed as described below. A DNA fragment of Hog1 was amplified by PCR using a 5 0 primer with a HindIII site (5 0 -GGCAAGCTTATAATAATGACCACTAACGAGGAATT-3 0 ), a 3 0 primer (5 0 -GCACCGTCACCCTGTTGGAACTCATTAGC GTA-3 0 ), and yeast genomic DNA as a template. A DNA fragment of yeGFP was amplified by PCR using a 5 0 primer (5 0 -AGTTCCAACAGGGTGACGGTGCTGGTTTAATT-3 0 ), a 3 0 primer with a BamHI site (5 0 -ACTGGATCCTTATTTGTAC AATTCATCCATACCATG-3 0 ) and pKT172 (Sheff and Thorn, 2004 ) as a template. These two DNA fragments were extended by PCR. The fragment obtained was digested with HindIII and BamHI and then subcloned into a single-copy plasmid [pRS415-TEFp (Tani and Kuge, 2010b) ].pRS416-7xSTRE-MEL1, a plasmid expressing a-galactosidase (Mel1) under the control of seven tandem repeats of the stress response element (STRE; GGTAAGGGGCCAA) and an LEU2 upstream sequence containing both its transcriptional and translational start site but lacking the leucine-responsive region (Martinez-Arias et al., 1984; Marchler et al., 1993) , was constructed as follows. The open reading frame of MEL1 was amplified by PCR using a 5 0 primer (5 0 -GGATATACCATTCTAATGTTTGC TTTCTACTTTCTCACC-3 0 ), a 3 0 primer with a NotI site (5 0 -AGAGCGGCCGCGTGGAACACCAACGCCACTA-3 0 ) and pT7Blue 1 MEL1 (provided by the National Bio-Resource Project (NBRP), Japan) as a template. The LEU2 upstream sequence was amplified by PCR using a 5 0 primer with a EcoRI site (5 0 -CAAGAATTCCCGACAATATTATTTAAGGA CCTATTGTT-3 0 ), a 3 0 primer (5 0 -AAAGCAAACATTAGAA TGGTATATCCTTGAAATATATATATATAT-3 0 ) and pRS405 (Sikorski and Hieter, 1989 ) as a template. These two DNA fragments were extended by PCR. The fragment obtained was digested with EcoRI and NotI, and then subcloned into pRS416 (Sikorski and Hieter, 1989 ) (pRS416-LEU2-MEL1). A DNA fragment containing seven tandem repeats of STRE was obtained by dimerization of a 5 0 primer with a HindIII site (5 0 -GATAAGCTTGGTAAGGGGCCAAGGTAAGGGGCC AAGGTAAGGGGCCAAGGTAAGGGGCCAAGGTAAGGGG CCAAGGTAAGGGGCCAAGAATTCAAC-3 0 ) and a 3 0 primer with a EcoRI site (5 0 -GTTGAATTCTTGGCCCCTT ACCTTGGCCCCTTACCTTGGCCCCTTACCTTGGCCCCTT ACCTTGGCCCCTTACCTTGGCCCCTTACCAAGCTTATC-3 0 ). The DNA fragment was digested with HindIII and EcoRI and then subcloned into pRS416-LEU2-MEL1.pRS416-GRE2p--MEL1, a plasmid expressing MEL1 under the control of the GRE2 promoter region (Rienzo et al., 2012) , was constructed as follows. The 5 0 -untranslated region (1000 bp) of GRE2 was amplified by PCR using a 5 0 primer with a XhoI site
, and yeast genomic DNA as a template. The open reading frame of MEL1 was amplified by PCR using a 5 0 primer (5 0 -CGCCCGTAAATATGTTTGCTTTCTACTTTCTCACC-3 0 ), a 3 0 primer with a NotI site (5 0 -AGAGCGGCCGCGTGG AACACCAACGCCACTA-3 0 ), and pT7Blue 1 MEL1 as a template. These two DNA fragments were extended by PCR. The fragment obtained was digested with XhoI and NotI, and then subcloned into pRS416.
A single-copy plasmid (pRS415) containing 3xHA-SSK1 or 3xHA-SSK1-D554N with the TEF promoter and 3 0 -untranslated regions (350 bp) was constructed as described below. For tagging of the N-terminus of Ssk1 with a 3xHA tag, a 3xHA fusion cassette with the TEF promoter and natNT2 marker from the pYM-N20 vector was introduced immediately downstream of the initiator ATG of chromosomal SSK1 as described previously (Janke et al., 2004) . A DNA fragment was amplified by PCR using a 5 0 primer with a NotI site (5 0 -AGAGCGGCCGCATAGCTTCAAAATGTTTCTACTCC TT-3 0 ), a 3 0 primer with a XhoI site (5 0 -CCCCTCGAGGGC TGTGAATCCAAGCCCG-3 0 ), and genomic DNA of the TEFp-3xHA-SSK1::natNT2 strain as a template. A DNA fragment of TEFp-3xHA-SSK1-D554N was obtained by fusing the upstream and downstream DNA fragments of TEFp-3x-HA-SSK1. The upstream fragment was amplified with a 5'primer with a NotI site (5 0 -AGAGCGGCCGCATAGCTTC AAAATGTTTCTACTCCTT-3 0 ), a 3 0 -primer (5 0 -CAGGCAGC TGTAAATTCATAAATATTAAA-3 0 ; the underlining shows the location of the mutation), and genomic DNA of the TEFp-3x-HA-SSK1::natNT2 strain as a template. The downstream fragment was amplified with a 5 0 primer (5 0 -TTTAATATTTAT-GAATTTACAGCTGCCTG-3 0 ; the underlining shows the location of the mutation), a 3 0 -primer with a XhoI site (5 0 -CCCC TCGAGGGCTGTGAATCCAAGCCCG-3 0 ), and genomic DNA of TEFp-3xHA-SSK1::natNT2 strain as a template. These fragments were extended by PCR, digested with NotI and XhoI, and then subcloned into pRS415.
Isolation of mutants exhibiting resistance to the growth defect caused by AUR1 repression
Mutagenesis by random insertion of the transposon mTnlacZ/LEU2 was performed as described previously (Burns et al., 1994) using a yeast genomic library kindly provided by Dr. Michael Snyder (Stanford University, Stanford, CA) and Dr. Akio Kihara (Hokkaido University, Sapporo, Japan). The library was digested with NotI, and the resultant DNA fragments were transformed into tet-AUR1 cells. The transformed cells were plated on SC/MSG plates lacking leucine but containing 10 mg/ml of doxycycline (Dox), in which AUR1-repressed cells can not grow, and then incubated for 3 days. The mutants showing resistance against AUR1 repression were isolated, and the sites of transposon insertion were identified as described in (Sano et al., 2005) .
Multicopy suppressor screening
A S. cerevisiae genomic DNA library based on YEp13, a multicopy vector with the LEU2 marker (kindly provided by Dr. Akihiko Nakano, RIKEN, Japan), was introduced into tet-AUR1 cells. After the transformation, the cells were plated on SC/MSG plates lacking leucine but containing 10 mg/ml Dox, and then incubated at 308C for 3 days. Colonies were re-streaked onto SC/MSG plates lacking leucine but containing 10 mg/ml Dox, and the growth was confirmed. Plasmid DNA from positive clones was isolated and amplified in Escherichia coli, and the DNA sequences were verified with an ABI PRISMV R 3100 genetic analyzer (Applied Biosystems, Foster, CA).
Lipid extraction and TLC analysis
Lipids were extracted from S. cerevisiae as described previously (Hanson and Lester, 1980) with minor modifications. Briefly, cells [3 A 600 U (for detection of complex sphingolipids or glycerophospholipids), 5 A 600 U (for detection of Cer-C) or 1.5 A 600 U (for detection of ergosterol)] were suspended in 350 ml of ethanol/water/diethyl ether/pyridine/ 15 M ammonia (15:15:5:1:0.018, v/v), and then incubated at 658C for 15 min. The lipid extract was centrifuged at 10 000 g for 1 min and then extracted once more in the same manner. For analysis of sphingolipids, the resulting supernatants were dried and subjected to mild alkaline treatment using monomethylamine (MMA). For this reason, the lipid extracts were dissolved in 130 ml MMA (40% methanol solution)/water (10:3, v/v), incubated for 1 h at 538C, and then dried. The lipids were suspended in 50 ml of chloroform/methanol/water (5:4:1, v/v), and then separated on Silica Gel 60 TLC plates (Merck, Whitehouse Station, NJ) with chloroform/methanol/4.2 M ammonia (9:7:2, v/v) (for detection of complex sphingolipids), chloroform/methanol/ acetic acid (100:6:0.6, v/v) (for detection of Cer) or hexane/ diethyl ether/acetic acid (30:70:1, v/v) (for detection of ergosterol) as the solvent system. Glycerophospholipids were separated on a LK5 silica gel 150 A TLC plate (Whatman, Clifton, NJ), which had been pre-washed in chloroform/methanol (1:1, v/v) and treated with 2% boric acid in ethanol. The TLC plates were developed two times with chloroform/ethanol/water/triethylamine (30:35:7:35, v/v) (Vaden et al., 2005) . The TLC plates were sprayed with 10% copper sulfate in 8% orthophosphoric acid and then heated at 1808C to visualize lipids. Identification of each complex sphingolipid, Cer-C, and glycerophospholipid (PC, PI, PS, PE and PA) was performed as described in previous papers (Vaden et al., 2005; Tani and Kuge, 2010a; Uemura et al., 2014; Tani and Toume, 2015) .
Enzyme assay for a-galactosidase a-Galactosidase assays were carried out as described previously (Ryan et al., 1998) with minor modifications. Briefly, cells (1 A 600 U) were suspended in 200 ml of 20 mM TrisHCl buffer, pH 7.5, containing 0.35% 2-mercaptoethanol and 0.002% SDS (buffer A), 5 ml of chloroform was added, and then the samples were vortexed for 10 s. For measurement of the activity of a-galactosidase expressed by 7xSTRE, the samples were diluted 10-fold with buffer A. After 5 min pre-incubation at 308C, the samples (200 ml) were mixed with 80 ml of 7 mM p-nitrophenyl-a-galactoside (Sigma) in 100 mM citric acid buffer, pH 4.0, and then incubated at 308C for 15 min. Following quenching of the reaction with 900 ml of 0.1 M NaOH, samples were centrifuged at 10 000 g for 1 min, and the OD 410 of the supernatants was measured.
Yeast protein extraction, SDS-PAGE and Western blotting
Protein extraction, SDS-PAGE and Western blotting were performed as described elsewhere (Tani and Kuge, 2010b) with some modifications. For protein extraction, yeast cells grown in YPD medium were collected by centrifugation, washed with water and then re-suspended in 100 ml of 0.2 N NaOH containing 0.5% 2-mercaptoethanol. The suspension was incubated on ice for 15 min. One ml of ice-cold acetone was added to the suspension, followed by incubation for 30 min at 2258C, and then the proteins were precipitated by centrifugation for 10 min at 10 000 g. The pellet was re-suspended in 100 ml of SDS sample buffer (156 mM Tris-HCl, pH 6.8, containing 5% SDS, 25% glycerol, 5% 2-mercaptoethanol and 0.001% bromophenol blue). The suspension was mixed well, heated for 3 min at 958C, and then centrifuged for 2 min at 10 000 g. Then the supernatant was separated by SDS-PAGE according to the method of Laemmli (1970) . For Western blotting, anti-HA (Sigma), anti-FLAG (Sigma), anti-phospho-p38 MAPK (Cell Signaling Technology, Danvers, MA), anti-Hog1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-Pgk1 (Molecular Probes, Carlsbad, CA) were used as primary antibodies. Horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG (Molecular Probes) was used as the secondary antibody. 
